Common Stock, Shares, Issued of DermTech, Inc. from 31 Mar 2017 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
DermTech, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Mar 2017 to 31 Mar 2024.
  • DermTech, Inc. Common Stock, Shares, Issued for the quarter ending 31 Mar 2024 was 34,962,994, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

DermTech, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 34,962,994 +3,874,083 +12% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 34,524,677 +4,227,269 +14% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 34,241,523 +4,028,317 +13% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 33,408,810 +3,370,363 +11% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 31,088,911 +1,148,274 +3.8% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 30,297,408 +524,486 +1.8% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 30,213,206 +496,008 +1.7% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 30,038,447 +431,053 +1.5% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 29,940,637 +1,021,385 +3.5% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 29,772,922 +9,032,509 +44% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 29,717,198 +10,126,200 +52% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 29,607,394 +11,378,030 +62% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 28,919,252 +14,019,551 +94% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 20,740,413 +8,395,595 +68% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 19,590,998 +7,626,669 +64% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 18,229,364 +12,954,788 +246% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 14,899,701 +9,638,870 +183% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 12,344,818 +7,933,251 +180% 31 Dec 2019 10-K 05 Mar 2021 2020 FY
Q3 2019 11,964,329 +6,800,296 +132% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 5,274,576 +171,835 +3.4% 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
Q1 2019 5,260,831 +169,760 +3.3% 31 Mar 2019 10-Q 13 Aug 2019 2020 Q1
Q4 2018 4,411,567 -674,495 -13% 31 Dec 2018 10-K 11 Mar 2020 2019 FY
Q3 2018 5,164,033 +85,378 +1.7% 30 Sep 2018 10-Q 14 Nov 2018 2019 Q2
Q2 2018 5,102,741 +32,181 +0.64% 30 Jun 2018 10-Q 10 Aug 2018 2019 Q1
Q1 2018 5,091,071 +778,571 +18% 31 Mar 2018 10-K 14 Jun 2019 2019 FY
Q4 2017 5,086,062 31 Dec 2017 10-Q 13 Feb 2018 2018 Q3
Q3 2017 5,078,655 30 Sep 2017 10-Q 13 Nov 2017 2018 Q2
Q2 2017 5,070,560 30 Jun 2017 10-Q 14 Aug 2017 2018 Q1
Q1 2017 4,312,500 31 Mar 2017 10-K 29 Jun 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.